Scheduling cisplatin and radiotherapy in the treatment of squamous cell carcinomas of the head and neck: A modelling approach

Physics in Medicine and Biology

Volumn 51, Issue 15, 2006, Pages 3625-3637

  Marcu, L ^a,b   Bezak, E ^a,b   Olver, I ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; COMPUTER SIMULATION; DRUG DOSAGE; MATHEMATICAL MODELS; MEDICAL APPLICATIONS; RADIOTHERAPY; TUMORS;

CISPLATIN; CYTOTOXINS; RADIOSENSITIZATION; SQUAMOUS CELL CARCINOMAS;

SCHEDULING;

CISPLATIN;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL KILLING; CLINICAL TRIAL; DRUG EFFECT; HEAD AND NECK CARCINOMA; HUMAN; KINETICS; MEDICAL LITERATURE; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIZATION; SQUAMOUS CELL CARCINOMA;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; KINETICS; MODELS, THEORETICAL; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TIME FACTORS;

EID: 33746565896     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/51/15/002     Document Type: Article

References (29)

1. Bartelink H, Kallman R F, Rapacchietta D and Hart G 1985 Therapeutic enhancement in mice by clinically relevant dose and fractionation schedules of cis-diamminedichloroplatinum (II) and irradiation Radiother. Oncol. 6 61-74
2. Begg A C 1990 Cisplatin and radiation: interaction probabilities and therapeutic possibilities Int. J. Radiat. Biol. Oncol. Phys 19 1183-9
3. Davis A J and Tannock I F 2000 Repopulation of tumour cells between cycles of chemotherapy: a neglected factor Lancet Oncol. 1 86-93
4. Dewit L 1987 Combined treatment of radiation and cis- diamminedichloroplatinum (II): a review of experimental and clinical data Int. J. Radiat. Biol. Oncol. Phys. 13 403-26
5. Dewit L, Oussoren Y and Bartelink H 1985 Dose and time effects of cis-diamminedichloroplatinum (II) and radiation on mouse duodenal crypts Radiother. Oncol. 4 363-71
6. Douple E B and Richmond R C 1979 A review of platinum complex biochemistry suggests a rationale for combined platinum-radiotherapy Int. J. Radiat. Biol. Oncol. Phys. 5 1335-9
7. Fountzilas G et al 1994 Radiation therapy and concurrent cisplatin administration in locally advanced head and neck cancer. A Hellenic co-operative oncology group study Acta Oncol. 33 825-30
8. Gasparini G et al 1991 Simultaneous cis-platinum and radiotherapy in inoperable or locally advanced squamous cell carcinoma of the head and neck Oncology 48 270-6
9. Hoglmeier F, Kummermehr J and Trott K R 1985 Effect of a combination therapy of cisplatin and local irradiation on a mouse fibrosarcoma Strahlentherapie 161 362-6
10. Jeremic B et al 2000 Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial J. Clin. Oncol. 18 1458-64
11. Kallman R F, Bedarida G and Rapacchietta D 1992 Experimental studies on schedule dependence in the treatment of cancer with combinations of chemotherapy and radiotherapy Radiotherapy/Chemotherapy Interactions in Cancer Therapy ed J L Meyer and J M Vaeth (Basel: Karger)
12. Kanazawa H, Rapacchietta D and Kallman R F 1988 Schedule-dependent therapeutic gain from the combination of fractionated irradiation and cis-diamminedichloroplatinum in C3H/Km mouse model system Cancer Res. 48 3158-64
13. Korbelik M and Skov K A 1989 Inactivation of hypoxic cells by cisplatin and radiation at clinically relevant doses Radiat. Res. 119 145-56
14. Lawrence T S, Blackstock A W and McGinn C 2003 The mechanism of action of radiosensitization of conventional chemotherapeutic agents Semin. Radiat. Oncol. 13 13-21
15. Lippert B 1999 Cisplatin-Chemistry and Biochemistry of A Leading Anticancer Drug (Zürich: Wiley-VCH)
16. Malaise E P, Fertil B, Chavaudra N and Guichard M 1986 Distribution of radiation sensitivities for human tumor cells of specific histological types: comparison of in vitro to in vivo data Int. J. Radiat. Biol. Oncol. Phys. 12 617-24
17. Marcu L, van Doorn T and Olver I 2003 Cisplatin and radiotherapy in the treatment of locally advanced head and neck cancer Acta Oncol. 42 315-25
18. Marcu L, van Doorn T, Zavgorodni S and Olver I 2002 Growth of a virtual tumour using probabilistic methods of cell generation Aust. Phys. Eng. Sci. Med. 25 155-61
19. Nakamoto S et al 1996 An interaction of cisplatin and radiation in two rat yolk sac tumour cell lines with different radiosensitivities in vitro Int. J. Radiat. Biol. 70 747-53
20. Overgaard J and Khan A R 1981 Selective enhancement of radiation response in a C3H mammary carcinoma by cisplatin Cancer Treat. Rep. 65 501-3
21. Prestayko A W, Crooke S T and Carter S K 1980 Cisplatin-Current Status and New Developments (New York: Academic)
22. Reed E and Kohn K W 1990 Platinum analogues Cancer Chemotherapy- Principles and Practice ed B Chabner and J M Collins (Philadelphia, PA: Lippincott)
23. Schwachöfer J H et al 1991 Effectiveness in inhibition of recovery of cell survival by cisplatin and carboplatin: influence of treatment sequence Int. J. Radiat. Biol. Oncol. Phys. 20 1235-41
24. Sinclair W K 1969 Dependence of radiosensitivity upon cell age Proc. Carmel Conf. on Time and Dose Relationships in Radiation Biology as Applied to Radiotherapy. BNL Report 50203 (Upton, New York) pp 97-107
25. Slotman G J et al 1986 Preoperative simultaneously administered cis-platinum plus radiation therapy for advanced squamous cell carcinoma of the head and neck Head Neck Surg. 8 159-64
26. Sorenson C M, Barry M A and Eastman A 1990 Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin J. Nat. Cancer Inst. 82 749-54
27. Steel G G 1992 Principles for the combination of radiotherapy and chemotherapy Combined Radiotherapy and Chemotherapy in Clinical Oncology ed A Horwich (London: Edward Arnold)
28. Sun J R and Brown J M 1993 Lack of differential radiosensitization of hypoxic cells in a mouse tumor at low radiation doses per fraction by cisplatin Radiat. Res. 133 252-6
29. Yoshikawa A, Saura R, Matsubara T and Mizuno K 1997 A mechanism of cisplatin action: antineoplastic effect through inhibition of neovascularization Kobe J. Med. Sci. 43 109-20